Print

Cyclacel Pharmaceuticals, Inc. (CYCC) to Present at Stifel Nicolaus 2012 Healthcare Conference  
8/29/2012 9:19:47 AM

BERKELEY HEIGHTS, N.J., Aug. 29, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, announced today that Spiro Rombotis, President and Chief Executive Officer, will present at the Stifel Nicolaus 2012 Healthcare Conference on Wednesday, September 5th at 2:40 PM Eastern Time at The Four Seasons Hotel in Boston.